Iron deficient | Non-iron deficient | P value | |||||
Sample size (n) | Cancer* (n) | Incidence/1000 patients (95% CI) | Sample size (n) | Cancer* (n) | Incidence/1000 patients (95% CI) | ||
Anaemic women (n=9783) | |||||||
Gastric cancer | |||||||
Age 20–49 years | 6627 | 4 | 0.60 (0.23 to 1.55) | 3156 | 2 | 0.63 (0.17 to 2.31) | >0.99 |
20–29 | 379 | 0 | – | 269 | 0 | – | – |
30–39 | 1656 | 3 | 1.81 (0.62 to 5.31) | 935 | 0 | – | 0.56 |
40–49 | 4592 | 1 | 0.22 (0.04 to 1.23) | 1952 | 2 | 1.02 (0.28 to 3.73) | 0.21 |
Colon cancer | |||||||
Age 20–49 years | 6627 | 18 | 2.72 (1.72 to 4.29) | 3156 | 8 | 2.53 (1.29 to 4.99) | 0.87 |
20–29 | 379 | 1 | 2.64 (0.47 to 14.79) | 269 | 0 | – | >0.99 |
30–39 | 1656 | 5 | 3.02 (1.29 to 7.05) | 935 | 2 | 2.14 (0.59 to 7.77) | >0.99 |
40–49 | 4592 | 12 | 2.61 (1.50 to 4.56) | 1952 | 6 | 3.07 (1.41 to 6.69) | 0.74 |
Non-anaemic women (n=22 657) | |||||||
Gastric cancer | |||||||
Age 20–49 years | 6979 | 0 | – | 15 678 | 3 | 0.19 (0.07 to 0.56) | 0.56 |
20–29 | 1010 | 0 | – | 2122 | 0 | – | – |
30–39 | 2068 | 0 | – | 5076 | 0 | – | – |
40–49 | 3901 | 0 | – | 8480 | 3 | 0.35 (0.12 to 1.04) | 0.56 |
Colon cancer | |||||||
Age 20–49 years | 6979 | 16 | 2.29 (1.41 to 3.72) | 15 678 | 12 | 0.77 (0.44 to 1.34) | 0.003 |
20–29 | 1010 | 0 | – | 2122 | 0 | – | – |
30–39 | 2068 | 1 | 0.48 (0.09 to 2.73) | 5076 | 1 | 0.20 (0.03 to 1.12) | 0.50 |
40–49 | 3901 | 15 | 3.85 (2.33 to 6.33) | 8480 | 11 | 1.30 (0.72 to 2.32) | 0.01 |
Comparisons were made using Fisher’s exact tests.
–, not applicable.
*Within 5 years of the iron deficiency test date.